Skip to main content
/
Chugai Pharmaceutical Co., Ltd. (CHGCF)
OTCMKTS · Delayed Price · Currency is USD
51.58
-0.05 (-0.10%)
At close: Jun 9, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 TTMFY 2024FY 2023FY 2022FY 2021 2012 - 2020
Period Ending
 Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2012 - 2020
Overseas
592.20B
Log In
Log In
Log In
Log In
Upgrade
Overseas Growth
41.37%
Log In
Log In
Log In
Log In
Upgrade
Royalties and Other Operating Income
168.90B
Log In
Log In
Log In
Log In
Upgrade
Royalties and Other Operating Income Growth
13.58%
Log In
Log In
Log In
Log In
Upgrade
Domestic Oncology
-
Log In
Log In
Log In
Log In
Upgrade
Domestic Oncology Growth
-
Log In
Log In
Log In
Log In
Upgrade
Domestic Specialty
-
Log In
Log In
Log In
Log In
Upgrade
Domestic Specialty Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-
Log In
Log In
Log In
Log In
Upgrade